MHRARegulatory
Single-dose 7.2mg semaglutide (Wegovy) pen approved to treat adult patients with obesity
14 Apr 20260 views
Summary
As with any medicine, the MHRA will keep the safety and effectiveness of Wegovy under close review.
As with any medicine, the MHRA will keep the safety and effectiveness of Wegovy under close review.